For instance, elevated levels of YTHDF1 and YTHDC2 are adverse prognostic factors for gastric cancer (GC) [10,11], while increased IGF2BP3 levels are adverse prognostic factors for bladder cancer [12]. This evidence concerns the gene IGF2BP3 and urinary bladder carcinoma.